These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8202694

  • 21. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
    Mohacsi PJ, Tüller D, Hulliger B, Wijngaard PL.
    J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
    [Abstract] [Full Text] [Related]

  • 22. Growth factors and vascular wall.
    Chabrier PE.
    Int Angiol; 1996 Jun; 15(2):100-3. PubMed ID: 8803632
    [Abstract] [Full Text] [Related]

  • 23. Endothelial control of vascular smooth muscle proliferation in an organ culture of human saphenous vein.
    Soyombo AA, Thurston VJ, Newby AC.
    Eur Heart J; 1993 Nov; 14 Suppl I():201-6. PubMed ID: 8293778
    [Abstract] [Full Text] [Related]

  • 24. Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces.
    Lüscher TF.
    Blood Press Suppl; 1994 Nov; 1():18-22. PubMed ID: 8205293
    [Abstract] [Full Text] [Related]

  • 25. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA, Griffin MO, Guttormsen B, Stoker S, Wolff MR.
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [Abstract] [Full Text] [Related]

  • 26. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
    Isenberg JS, Calzada MJ, Zhou L, Guo N, Lawler J, Wang XQ, Frazier WA, Roberts DD.
    Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
    [Abstract] [Full Text] [Related]

  • 27. [Role of the hematocrit and platelet count in the interaction of the platelets with the subendothelium].
    Garrido M, Escolar G, Ordinas A.
    Sangre (Barc); 1987 Apr; 32(4):445-52. PubMed ID: 3660182
    [No Abstract] [Full Text] [Related]

  • 28. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases].
    Limone P, Boeri E, Molinatti GM.
    Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303
    [Abstract] [Full Text] [Related]

  • 29. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
    Vanhoutte PM.
    Schweiz Rundsch Med Prax; 1993 Oct 19; 82(42):1161-6. PubMed ID: 8248687
    [Abstract] [Full Text] [Related]

  • 30. Endothelial dysfunction and vascular disease.
    Vanhoutte PM.
    Verh K Acad Geneeskd Belg; 1998 Oct 19; 60(3):251-66. PubMed ID: 9803882
    [Abstract] [Full Text] [Related]

  • 31. [Vascular endothelium and vascular smooth muscle cells].
    Saito Y, Nakamura T, Nagai R.
    Nihon Rinsho; 2000 Jan 19; 58 Suppl 1():335-9. PubMed ID: 11026286
    [No Abstract] [Full Text] [Related]

  • 32. Modulation of vascular reactivity by endothelium derived factors.
    Reid JJ.
    Proc West Pharmacol Soc; 1993 Jan 19; 36():81-7. PubMed ID: 8378403
    [No Abstract] [Full Text] [Related]

  • 33. Endothelium-dependent hyperpolarization of vascular smooth muscle cells.
    Félétou M, Vanhoutte PM.
    Acta Pharmacol Sin; 2000 Jan 19; 21(1):1-18. PubMed ID: 11263241
    [Abstract] [Full Text] [Related]

  • 34. The endothelium--modulator of vascular smooth-muscle tone.
    Vanhoutte PM.
    N Engl J Med; 1988 Aug 25; 319(8):512-3. PubMed ID: 3405258
    [No Abstract] [Full Text] [Related]

  • 35. Influence of heat on platelet biochemistry, structure, and function.
    Rao GH, Smith CM, Escolar G, White JG.
    J Lab Clin Med; 1993 Oct 25; 122(4):455-64. PubMed ID: 8228561
    [Abstract] [Full Text] [Related]

  • 36. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ.
    J Clin Invest; 1994 Jan 25; 93(1):204-11. PubMed ID: 8282789
    [Abstract] [Full Text] [Related]

  • 37. The influence of oxidized lipoproteins, oxidation products and antioxidants on the release of nitric oxide from the endothelium and the response of platelets to nitric oxide.
    Bruckdorfer KR, Naseem KM, Mohammadi B, Chirico S, Ettelaie C, Gleeson A, Young T, Adam JM, Wilbourn B, Skinner VO, Goodall AH, Khan J, Gates SC, Jacobs M.
    Biofactors; 1997 Jan 25; 6(2):191-9. PubMed ID: 9260001
    [No Abstract] [Full Text] [Related]

  • 38. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.
    Akopov S, Sercombe R, Seylaz J.
    Cerebrovasc Brain Metab Rev; 1996 Jan 25; 8(1):11-94. PubMed ID: 9052980
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.